News

Sobi® (STO: SOBI), a global biopharmaceutical company dedicated to delivering innovative treatments for patients with rare diseases, and ...
From hydration status to physical activity and muscle mass, here is a list of daily habits that can fuel or ruin the overall ...
Eli Lilly's Mounjaro helped children and adolescents aged 10 to 17 years with type 2 diabetes manage their blood sugar better ...
Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable ...
Heart attacks are caused by the sudden occlusion of any of the 3 coronary arteries or their branches supplying blood to the ...
BASF, Arkema, and AkzoNobel have reduced the carbon footprint of AkzoNobel’s Interpon D superdurable architectural powder coatings by up to 40% ...
Ultimately, in consultation with her oncologist, Katie selected ALUNBRIG ® (brigatinib) as her first-line treatment option, ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that yesterday it filed a Complaint for Declaratory Judgment in the United States District Court for the District of Delaware against ...
The indication for the chemotherapy-containing system stipulates use in adults with bacillus Calmette-Guerin (BCG)-unresponsive NMIBC with carcinoma in situ -- with or without papillary tumors -- and ...
Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration (FDA) approved INLEXZO™ (gemcitabine intravesical system), a new, potentially practice-changing approach for treating ...
IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:50 PM EDT ...
First and only drug releasing system to provide extended local delivery of a cancer medication into the bladder, with 82 percent of patients achieving complete response without the need for ...